SPINK1 expression in PCa has been associated with poor response to ADT, faster progression to castrate-resistant stage and cancer-associated mortalities5,8,9, thus highlighting its significance as a biomarker of aggressivity and poor clinical response. Here, SPINK1 is linked to cancer.